Difference between revisions of "Miinalainen IJ"
From Bioblast
Marte Verena (talk | contribs) |
Marte Verena (talk | contribs) |
||
| Line 10: | Line 10: | ||
|country=Finland | |country=Finland | ||
|weblink=[www.oulu.fi/biocenter/em] | |weblink=[http://www.oulu.fi/biocenter/em] | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Revision as of 14:13, 20 June 2013
| Name | Miinalainen Ilkka, Ph.D. |
|---|---|
| Institution | Biocenter Oulu Electron Microscopy Core Facility
University of Oulu |
| Address | Aapistie 5A, 90220 |
| City | Oulu |
| State/Province | |
| Country | Finland |
| [email protected] | |
| Weblink | [1] |
| O2k-Network Lab | IE Dublin Miinalainen I |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Raesaenen 2016 Proc Natl Acad Sci U S A | 2016 | Räsänen M, Degerman J, Nissinen TA, Miinalainen I, Kerkelä R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivelä R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49. |
